Literature DB >> 17510412

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

Maria M Ho1, Alvin V Ng, Stephen Lam, Jaclyn Y Hung.   

Abstract

Stem cells have been isolated by their ability to efflux Hoechst 33342 dye and are referred to as the "side population" (SP). In this study, we used flow cytometry and Hoechst 33342 dye efflux assay to isolate and characterize SP cells from six human lung cancer cell lines (H460, H23, HTB-58, A549, H441, and H2170). Nonobese diabetic/severe combined immunodeficiency xenograft experiments showed that SP cells were enriched in tumor-initiating capability compared with non-SP cells. Matrigel invasion assay showed that SP cells also have higher potential for invasiveness. Further characterization of this SP phenotype revealed several stem cell properties. We found evidence for repopulating ability by SP to regenerate a population resembling the original population. SP displayed elevated expression of ABCG2 as well as other ATP-binding cassette transporters and showed resistance to multiple chemotherapeutic drugs. Human telomerase reverse transcriptase expression was higher in the SP, suggesting that this fraction may represent a reservoir with unlimited proliferative potential for generating cancer cells. mRNA levels of minichromosome maintenance (MCM) 7, a member of the MCM family of proteins critical to the DNA replication complex, were lower in SP cells, suggesting that a majority of the SP fraction was in the G(0) quiescent state. Sixteen clinical lung cancer samples also displayed a smaller but persistent SP population. These findings indicate that SP is an enriched source of lung tumor-initiating cells with stem cell properties and may be an important target for effective therapy and a useful tool to investigate the tumorigenic process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510412     DOI: 10.1158/0008-5472.CAN-06-3557

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  402 in total

Review 1.  The role of epigenetic regulation in stem cell and cancer biology.

Authors:  Lilian E van Vlerken; Elaine M Hurt; Robert E Hollingsworth
Journal:  J Mol Med (Berl)       Date:  2012-06-02       Impact factor: 4.599

2.  Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Authors:  Vera S Donnenberg; Albert D Donnenberg; Ludovic Zimmerlin; Rodney J Landreneau; Rohit Bhargava; Ryan A Wetzel; Per Basse; Adam M Brufsky
Journal:  Cytometry B Clin Cytom       Date:  2010-04-30       Impact factor: 3.058

Review 3.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

4.  Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.

Authors:  Kaijie He; Tong Xu; Amir Goldkorn
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

5.  Effects of the Hedgehog pathway inhibitor GDC-0449 on lung cancer cell lines are mediated by side populations.

Authors:  Fei Tian; Josef Mysliwietz; Joachim Ellwart; Fernando Gamarra; Rudolf Maria Huber; Albrecht Bergner
Journal:  Clin Exp Med       Date:  2011-04-26       Impact factor: 3.984

6.  Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples.

Authors:  Maximilian Boesch; Elisabeth Hoflehner; Dominik Wolf; Guenther Gastl; Sieghart Sopper
Journal:  J Vis Exp       Date:  2017-05-10       Impact factor: 1.355

7.  Sijunzi decoction-treated rat serum induces apoptosis of side population cells in gastric carcinoma.

Authors:  Jianguang Jia; Yiyu Qin; Ligong Zhang; Chenxu Guo; Yaguo Wang; Xicheng Yue; Jun Qian
Journal:  Exp Ther Med       Date:  2017-11-24       Impact factor: 2.447

8.  Highly optimized DNA vaccine targeting human telomerase reverse transcriptase stimulates potent antitumor immunity.

Authors:  Jian Yan; Panyupa Pankhong; Thomas H Shin; Nyamekye Obeng-Adjei; Matthew P Morrow; Jewell N Walters; Amir S Khan; Niranjan Y Sardesai; David B Weiner
Journal:  Cancer Immunol Res       Date:  2013-07-17       Impact factor: 11.151

9.  miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.

Authors:  Lei Shi; Zhimin Wang; Guan Sun; Yi Wan; Jun Guo; Xingli Fu
Journal:  Neuromolecular Med       Date:  2014-04-29       Impact factor: 3.843

10.  "The development tumor model" to study and monitor the entire progression of both primary and metastatic tumors.

Authors:  Enrico Brognaro
Journal:  Tumour Biol       Date:  2013-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.